Literature DB >> 20166347

New-onset psoriasis following treatment with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C.

Amir Horev1, Sima Halevy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20166347

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  6 in total

Review 1.  Induction and exacerbation of psoriasis with Interferon-alpha therapy for hepatitis C: a review and analysis of 36 cases.

Authors:  M Afshar; A D Martinez; R L Gallo; T R Hata
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-06-01       Impact factor: 6.166

Review 2.  Interferon-β exacerbates Th17-mediated inflammatory disease.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Trends Immunol       Date:  2011-04-29       Impact factor: 16.687

Review 3.  Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity.

Authors:  Robert C Axtell; Chander Raman; Lawrence Steinman
Journal:  Clin Rev Allergy Immunol       Date:  2013-04       Impact factor: 8.667

Review 4.  Peginterferon alfa related psoriasis in a patient with acute hepatitis C and review of the literature.

Authors:  Muhammed Sait Dag; Zeynel Abidin Oztürk; Nimet Yılmaz; Hakan Cam; Abdurrahman Kadayıfçı
Journal:  Wien Klin Wochenschr       Date:  2013-08-03       Impact factor: 1.704

5.  A case of erythrodermia from exacerbated psoriasis vulgaris due to treatment of acute hepatitis C.

Authors:  Eva Lemmenmeier; Barbara Gaus; Patrick Schmid; Matthias Hoffmann
Journal:  BMC Dermatol       Date:  2016-05-26

6.  The Clinical Significance of Autoantibodies in Hepatitis C Patients Submitted to Interferon Treatment.

Authors:  Eduardo Rodrigues-Pinto; Helder Cardoso; Sofia Pimenta; Guilherme Macedo
Journal:  GE Port J Gastroenterol       Date:  2015-01-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.